Baidu
map

FDA:2型糖尿病患者每周注射一次艾塞那肽,血糖有望恢复正常

2017-10-25 Heather_z727 来宝网

今天,美国食品和药物管理局(FDA)批准2型糖尿病患者每周使用一次艾塞那肽注射悬浮液,新配方的艾塞那肽注射悬浮液得到了很大的改进,成人2型糖尿病患者除了饮食,锻炼和口服药物管理之外,可以每周进行单剂量的自我注射,用来控制血糖。

FDA批准2型糖尿病患者每周注射艾塞那肽】今天,美国食品和药物管理局(FDA)批准2型糖尿病患者每周使用一次艾塞那肽注射悬浮液,新配方的艾塞那肽注射悬浮液得到了很大的改进,成人2型糖尿病患者除了饮食,锻炼和口服药物管理之外,可以每周进行单剂量的自我注射,用来控制血糖

艾塞那肽不像其他的受体激动剂,它拥有独特的,不断更新的微球输送系统,旨在提供治疗水平活性成分的一致性,它可以帮助患者达到并保持稳定状态。创新的新配方艾塞那肽可以降低血糖水平,还可以帮助患者保持健康的体重。

临床试验过程中,参与者的平均糖化血红蛋白减少高达1.4%,不论是作为单一疗法还是附加二甲双胍、磺酰脲类或其他药物组合,在为期28周的实验过程中,参与者的糖化血糖蛋白水平都得到了良好的改善。出现不良反应的参与者为5%,最常见的不良反应为恶心,比例达到8.2%,除此之外,还有注射部位结节,人数达到10.5%。

艾塞那肽专为减轻病人方便,每周只需注射一次,药物管理也只需要三个简单的步骤,混合,解锁和注入。

研究人员表示:“我们了解医生们需要帮助2型糖尿病患者建立降低糖化血红蛋白的长久信心,艾塞那肽可以提高这种一致性,现在我们引入了一种改进的新配方,更加易于使用,效果也更加明显。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1383352, encodeId=bb741383352c7, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393616, encodeId=86fb13936168f, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474316, encodeId=7b1f14e4316fd, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255822, encodeId=38c425582296, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Oct 25 10:20:30 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1383352, encodeId=bb741383352c7, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393616, encodeId=86fb13936168f, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474316, encodeId=7b1f14e4316fd, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255822, encodeId=38c425582296, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Oct 25 10:20:30 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1383352, encodeId=bb741383352c7, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393616, encodeId=86fb13936168f, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474316, encodeId=7b1f14e4316fd, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255822, encodeId=38c425582296, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Oct 25 10:20:30 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1383352, encodeId=bb741383352c7, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393616, encodeId=86fb13936168f, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86756, encryptionId=4a9886e56ed, topicName=艾塞那肽)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UdV6ialcayj7Qv8RQm1mVfNYPKxjiaolxwglAZpCo6CwjTicOroW2Xb0Kxnc65viaxGpkuqHW7WzzbYgRLw3qooDoA/132, createdBy=04c22500137, createdName=紫砂壶, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474316, encodeId=7b1f14e4316fd, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Oct 27 01:11:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255822, encodeId=38c425582296, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Oct 25 10:20:30 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
    2017-10-25 Y—xianghai

    学习了新知识

    0

相关资讯

J CLIN INVEST :科学家发现新药可逆转糖尿病眼病!

对于数以百万计的美国人来说,他们的世界正在溶化成一个无法辨认的模糊视野。糖尿病性视网膜病是一种眼病,影响了3000万(与糖尿病斗争的三分之一人)美国人。随着患者的视力逐渐消失,它永远不会恢复,很少有治疗方法。

BMJ Open:温度每升高1 ℃,预计有10万人新发糖尿病

全球气温升高可能会对当前全球糖尿病流行产生影响。近期有研究者分析了美国14年的数据, 发现总体糖尿病发病率在较暖年份较高。

Diabetes Care:3c型糖尿病常被误诊为2型糖尿病而面临极高的健康风险!

糖尿病患者的健康由于医生无法识别其糖尿病类型而受到威胁,这是DiabetesCare报告中的一项新研究。

流感疫苗,糖友和家人一起打

入秋后气温转冷,是流感的高发季。普通人得了流感,可能扛一扛就过去了。但糖友若是得了流感,症状会比常人更严重。因此,糖友必须特别重视预防流感,最有效的方式就是打疫苗。

Lancet Diabetes Endo:II型糖尿病患者多因素干预对心脑血管事件和死亡的影响

研究结果认为,对于II型糖尿病患者接受多因素强化干预对复合冠状动脉事件预防和全因死亡率的降低效果与传统治疗相比未显示出明显的优势,但对于脑血管事件风险的预防效果较为显著

诊间日记:什么样的人容易得糖尿病?可以对号入座哦

因为年老、肥胖、少动等因素,胰岛素受体的敏感性下降,受体对胰岛素不敏感了,人体必须增加胰岛素的分泌才能达到原来的效果。长此下去、久而久之,胰腺就被耗竭,胰岛素分泌不足而发生糖尿病。这就是2型糖尿病的主要发病机制,专业上称胰岛素抵抗。2型糖尿病是一种多基因遗传病,是遗传因素与不健康生活方式共同作用的结果,有家族聚集现象。通过对2型糖尿病的家族分析发现:当父母之一为2型糖尿病患者时,子女患病的风险为4

Baidu
map
Baidu
map
Baidu
map